AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer.
AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer.
复制标题
AGPAT9 通过 KLF4/LASS2/V-ATPase 信号通路抵消乳腺癌中的酸性肿瘤微环境,从而抑制细胞生长、侵袭和转移。
DOI:
10.18632/oncotarget.4074
复制
发表时间:
2015-07-30
期刊:
影响因子:
--
通讯作者:
Zheng YL
中科院分区:
文献类型:
--
作者:
Fan SH;Wang YY;Wu ZY;Zhang ZF;Lu J;Li MQ;Shan Q;Wu DM;Sun CH;Hu B;Zheng YL
Human 1-acylglycerol-3-phosphate O-acyltransferase 9 (AGPAT9) is the gene identified from adipose tissue in 2007. We found AGPAT9 expression was significantly higher in poorly invasive MCF7 human breast cancer cells than the highly invasive MDA-MB-231 cells. AGPAT9 significantly inhibited the proliferation of breast cancer cells in vitro and in vivo. Live-cell imaging and transwell assays showed that AGPAT9 could significantly inhibit the migration and invasive capacities of breast cancer cells. The inhibitory effect of AGPAT9 on metastasis was also observed in vivo in lung metastasis model. AGPAT9 inhibited breast cancer cell proliferation, migration and invasion through, at least in part, suppressing the V-ATPase activity. In addition, increased AGPAT9 expression in MCF-7/ADR cells could increase the chemosensitivity to doxorubicin (Dox). Our findings suggest that increasing AGPAT9 expression may be a new approach that can be used for breast cancer treatment.